未登录

S

Silvano G. Cella

university of milan

H指数:30

被引数:2,781

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sphingolipidomic Profiling of Peripheral Blood Mononuclear Cells Reveals a Distinct Immunometabolic Signature Across Patients with Essential Obesity and Metabolic Syndrome Compared to Normal-Weight Healthy Subjects

外周血单核细胞的鞘脂组学分析揭示了与正常体重健康受试者相比，原发性肥胖和代谢综合征患者具有独特的免疫代谢特征

Journal of Clinical Medicine

IF2.9

2026-05-090

OAAI

Evaluation of the Sphingolipidomic Profile in Women with Anorexia Nervosa: Relationships with Parameters Related to Body Composition, Cardiovascular Function, Glucometabolic Homeostasis, and Lipoprotein Metabolism

神经节苷脂组学特征在神经性厌食症女性中的评估：与体成分、心血管功能、葡萄糖代谢稳态及脂蛋白代谢相关参数的关系

Journal of Clinical Medicine 2025, Vol. 14, Page 6482

IF2.9

2025-10-010

OAAI

Epigenetic Age in Prader-Willi Syndrome and Essential Obesity: A Comparison with Chronological and Vascular Ages

JOURNAL OF CLINICAL MEDICINE

IF2.9

2025-02-220

OAAI

Effects of Melatonin on Exercise-Induced Oxidative Stress in Adults with Obesity Undergoing a Multidisciplinary Body Weight Reduction Program

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-09-031

OAAI

Metabolomic profiling of Prader-Willi syndrome compared with essential obesity

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2024-05-151

OAAI

Characterizing non-communicable disease trends in undocumented migrants over a period of 10 years in Italy

SCIENTIFIC REPORTS

IF3.9

2023-05-082

OAAI

A Metabolomics-Based Investigation of the Effects of a Short-Term Body Weight Reduction Program in a Cohort of Adolescents with Obesity: A Prospective Interventional Clinical Study

IF5

2023-01-192

OAAI

Effect of a 3-Week Multidisciplinary Body Weight Reduction Program on the Epigenetic Age Acceleration in Obese Adults

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-08-107

OAAI

The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents (vol 12, 155, 2022)

IF3.7

2022-06-170

OAAI

The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents

IF3.7

2022-02-0811

OAAI

Frequent Medical Supervision Increases the Effectiveness of a Longitudinal Multidisciplinary Body Weight Reduction Program: A Real-World Experience in a Population of Children and Adolescents with Obesity

IF5

2021-09-256

OAAI

Effects of SARS-CoV-2 pandemic on follow-up and pharmacological treatment of chronic diseases in undocumented migrants

BMJ NUTRITION, PREVENTION & HEALTH

IF2.5

2021-07-022

OAAI

Evaluation of an Amino Acid Mix on the Secretion of Gastrointestinal Peptides, Glucometabolic Homeostasis, and Appetite in Obese Adolescents Administered with a Fixed-Dose or ad Libitum Meal

JOURNAL OF CLINICAL MEDICINE

IF2.9

2020-09-227

OAAI

Effects of a 3-Week In-Hospital Body Weight Reduction Program on Cardiovascular Risk Factors, Muscle Performance, and Fatigue: A Retrospective Study in a Population of Obese Adults with or without Metabolic Syndrome

IF5

2020-05-2113

OAAI

The Appetite-Suppressant and GLP-1-Stimulating Effects of Whey Proteins in Obese Subjects are Associated with Increased Circulating Levels of Specific Amino Acids

IF5

2020-03-1519

OAAI

Impact of a Three-Week in-Hospital Multidisciplinary Body Weight Reduction Program on Body Composition, Muscle Performance and Fatigue in a Pediatric Obese Population with or without Metabolic Syndrome

IF5

2020-01-1321

OAAI

Risk factors, awareness of disease and use of medications in a deprived population: differences between indigent natives and undocumented migrants in Italy

JOURNAL OF PUBLIC HEALTH

IF3.1

2019-11-084

PREAI

Multidisciplinary Integrated Metabolic Rehabilitation in Elderly Obese Patients: Effects on Cardiovascular Risk Factors, Fatigue and Muscle Performance

IF5

2019-05-3113

OAAI

Whey Proteins Reduce Appetite, Stimulate Anorexigenic Gastrointestinal Peptides and Improve Glucometabolic Homeostasis in Young Obese Women

IF5

2019-01-2324

OAAI

Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases

PULMONARY PHARMACOLOGY & THERAPEUTICS

IF2.8

2018-12-0115

PREAI